Large-scale testing (Phase 3)Study completedNCT00026338
What this trial is testing
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
Who this might be right for
Pancreatic Cancer
NCIC Clinical Trials Group 569